Search

The article discusses the constraints and advantages brought by the global financial turmoil to pharma sectors on CPhI, the pharmaceuticals ingredients conference, in Frankfurt, Germany. Pharma division of Piramal Healthcare president, R. Ananthanarayanan said that the economic downturn is in bad time for the sector but still early to identify its possible effects. Meanwhile, Aslam Malik, president of Ampac Fine Chemicals said that the crises could promote innovation and efficiency.

The article reports on Spain and its biotechnological researches as compared with other European countries including Germany, Switzerland and France. It mentions the Spanish Association of Bioenterprises (ASEBIO) and its statement that Spanish companies involved in biotechnology had an increase of 22 percent and that there is a notable gain in investments for biotechnological research. It also highlights the Spanish biotechnological companies Genetrix Inc. and Pharmamar SA.

The article reports that specialty and fine chemicals companies at the Chemspec Europe exhibition in Munich, Germany have reported an increased in demand for agricultural chemicals. Several factors attributed to the increase in demand include high energy and raw material costs and a strong euro. German custom chemicals manufacturer, Saltigo reported a 20 percent increased in its agricultural chemical revenues for the first five months of 2008.

Highlights the 14th Convention on Pharmaceutical Ingredients in Frankfurt, Germany. Number of attendees; Illustration of the new ventures across the broad filed of pharmaceutical chemistry; Inclusion of polymer technologies designed to enhance efficiency; Announcement of commercial availability of new technologies.

The article reports on the increase in Good Manufacturing Practice-certified capacity of the pharmaceutical chemical company Chemie Uetikon at its facility in Lahr, Germany. The facility will operate in conjunction with the company's first two trains, which began production in 2002. Details about business operations and strategies are cited.

Deals with the efforts of the business software sector in improving their sales around the world. Increase in the corporate profits of the German software company SAP; Efforts of the company in building an information technology (IT) device for the enterprise resource planning (ERP) software; Acquisition of the technology assets of e-Chemicals by AspenTech.

The article reports on talks with Klaus Engel, chairman of German chemical company Degussa, about the firm's disinvestments and business operations. Engel says that Degussa will focus on fine chemicals, specialty materials and consumer-product-oriented chemicals. He also says that RAG, which fully owns Degussa, will launch an initial public offering as a chemicals, energy and real estate group.

Provides information on Juelich Enzyme Products (JEP), a process development company that sells enzymes in Wiesbaden, Germany. License agreement of R ü tgers Organics with JEP; Efficiency of enzymatic process; Competitors of JEP.